- Home
- Companies
- usa california
- abdominal pain
Refine by
Abdominal Pain Suppliers In Usa California
5 companies found
based inSan Carlos, CALIFORNIA (USA)
Vibrant Wellness is a leading science and technology company delivering life-transforming laboratory services using an integrated microarray platform that enables multiplex testing at an affordable cost. Vibrant’s relationship with its patients and ...
Delayed sensitivities to peptides in tree nuts can present up to 72 hours after consuming tree nut products. These sensitivities are based on IgG & IgA antibody-driven reactions and can affect both the local intestinal environment with acute ...
based inCarlsbad, CALIFORNIA (USA)
Founded in 1996, IVD Research, Inc. is privately held by Dave Lambillotte, Ann Marie Martin and Christopher Lambillotte. Our tight-knit group of dedicated professionals works well as a team, each bringing their own unique experiences and education ...
Giardiasis, caused by the single-celled Giardia lambliaparasite, is the most common parasitic disease in the United States. As many as 100 million mild infections and 1 million severe infections are reported ...
based inBoca Raton, FLORIDA (USA)
Entero Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing targeted, orally delivered therapies for gastrointestinal (GI) diseases. At the core of its research are three proprietary technologies. Latiglutenase is an ...
based inMountain View, CALIFORNIA (USA)
G-Tech Medical has developed a wireless wearable patch system that measures GI motility non-invasively. Over 40 million patients visit gastroenterologists for GI conditions every year. Current options for assessing gastrointestinal activity to ...
G-Tech is developing a wearable medical technology that will be used to measure gastrointestinal (GI) motility. The G-Tech system will consist of wireless, wearable electrode patches that read electrical signals at the skin surface, a smartphone app ...
based inSan Rafael, CALIFORNIA (USA)
Established in 1997, BioMarin is a world leader in developing and commercializing first- or best-in-class therapies for rare genetic diseases. We take pride in going where the science leads us, pioneering breakthrough treatments for debilitating and ...
Vimizim (elosulfase alfa) is the first approved enzyme replacement therapy designed to address the underlying cause of Morquio A syndrome, or mucopolysaccharidosis IVA (MPS IVA) — a deficiency in the enzyme N-acetylgalactosamine-6 sulfatase ...